DXCM News and Press, DexCom Inc. From 07/31/23

2023-07-31 13:14:31 ET Summary Baillie Gifford's 13F portfolio value increased from ~$111B to ~$118B this quarter. The top three holdings are MercadoLibre, NVIDIA, and Tesla Motors, which make up ~17% of the portfolio. Baillie Gifford made stake increases in MercadoLibre, PDD ...

2023-07-30 07:10:00 ET Summary Baron is an asset management firm focused on delivering growth equity investment solutions known for a long-term, fundamental, active approach to growth investing. Baron Small Cap Fund had a strong performance in Q2 2023, up 6.49% and up 16.54% for t...

2023-07-30 06:20:00 ET Summary Baron is an asset management firm focused on delivering growth equity investment solutions known for a long-term, fundamental, active approach to growth investing. Baron Opportunity Fund outperformed the broader market in Q2 2023, with a 16.31% retur...

2023-07-28 01:00:57 ET Image source: The Motley Fool. DexCom (NASDAQ: DXCM) Q2 2023 Earnings Call Jul 27, 2023 , 4:30 p.m. ET Operator Continue reading For further details see: DexCom (DXCM) Q2 2023 Earnings Call Transcript

2023-07-27 20:14:09 ET Dexcom, Inc. (DXCM) Q2 2023 Earnings Conference Call July 27, 2023 04:30 PM ET Company Participants Sean Christensen - Director, Corporate Affairs & Head of IR Kevin Sayer - Executive Chairman, CEO & President Jereme Sylvain - EVP, ...

2023-07-27 16:05:49 ET DexCom press release ( NASDAQ: DXCM ): Q2 Non-GAAP EPS of $0.34 beats by $0.11 . Revenue of $871.3M (+25.2% Y/Y) beats by $30.35M . U.S. revenue growth of 21% and international revenue growth of 38% on a reported basis. International...

DexCom, Inc. (Nasdaq: DXCM) today reported its financial results as of and for the quarter ended June 30, 2023. Second Quarter 2023 Financial Highlights: Revenue grew 25% versus the same quarter of the prior year to $871.3 million on a reported basis and 26% on an organic 1 ba...

2023-07-23 21:25:42 ET Summary Actually the "bad news" is really good news as well, since they are affording a fantastic opportunity to buy on the cheap. How can we be having a new bull market when the best names could be falling? The rally is widening, other sectors are growing a...

2023-07-09 12:00:00 ET Despite a disappointing start to 2023, the healthcare sector has several promising industries waiting to outperform this year, Goldman Sachs said in a recent report after the bank concluded its annual healthcare conference in Dana Point, California, last month. Th...

2023-07-06 13:03:01 ET Summary DexCom's share price has increased by 414% over the last five years, driven by the company's innovative continuous glucose monitoring systems. Despite a high price-to-earnings ratio, the company has recently revised its 2025 growth targets upwards by...